SCHEMBL31378335

SCHEMBL31378335

NC(=O)CC[C@@H](N)C(=O)N[C@H](CCC(N)=O)C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.59
▸ ALOX15 P16050 1/20 0.59
▸ BLM P54132 1/20 0.59
▸ PMP22 Q01453 1/20 0.59
▸ DPP4 P27487 2/20 0.56
▸ DPP8 Q6V1X1 2/20 0.56
▸ DPP9 Q86TI2 2/20 0.56
▸ NOD1 Q9Y239 4/20 0.47
▸ CA2 P00918 5/20 0.46
▸ CA1 P00915 4/20 0.46
▸ FOLH1 Q04609 2/20 0.46
▸ RIMKLA Q8IXN7 1/20 0.46
▸ NAALAD2 Q9Y3Q0 1/20 0.46
▸ BMP1 P13497 1/20 0.41
▸ GRM8 O00222 1/20 0.41
▸ GRM6 O15303 1/20 0.41
▸ GRIN2D O15399 1/20 0.41
▸ GRIN3B O60391 1/20 0.41
▸ GSR P00390 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19375 1.00 KMT2A (0.59) KMT2AALOX15BLMPMP22DPP4
SCHEMBL5970495 1.00 KMT2A (0.59) KMT2AALOX15BLMPMP22DPP4
SCHEMBL29478367 0.96 KMT2A (0.55) KMT2AALOX15BLMPMP22DPP4
SCHEMBL31378337 0.96 KMT2A (0.55) KMT2AALOX15BLMPMP22DPP4
SCHEMBL29630337 0.96 KMT2A (0.55) KMT2AALOX15BLMPMP22DPP4
SCHEMBL31015849 0.96 KMT2A (0.55) KMT2AALOX15BLMPMP22DPP4
SCHEMBL31378334 0.95 FOLH1 (0.55) KMT2AALOX15BLMPMP22DPP4
SCHEMBL4726036 0.95 FOLH1 (0.55) KMT2AALOX15BLMPMP22DPP4
SCHEMBL19373 0.95 FOLH1 (0.55) KMT2AALOX15BLMPMP22DPP4
SCHEMBL8382466 0.95 FOLH1 (0.55) KMT2AALOX15BLMPMP22DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250019402-A1 PHARMACOKINETICS AND CHOLECYSTOKININ-2 RECEPTOR (CCK2R) TARGETING FOR DIAGNOSIS AND THERAPY MEDIZINISCHE UNIV INNSBRUCK (AT) 2025-01-16 — — US disclosed
Send feedback